The estimated Net Worth of Capital Management, L.P.Ra ... is at least $31.4 Million dollars as of 11 January 2024. Capital Ra owns over 904,160 units of Solid Biosciences Inc stock worth over $31,399,698 and over the last few years Capital sold SLDB stock worth over $0.
Capital has made over 1 trades of the Solid Biosciences Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently Capital bought 904,160 units of SLDB stock worth $5,000,005 on 11 January 2024.
The largest trade Capital's ever made was buying 904,160 units of Solid Biosciences Inc stock on 11 January 2024 worth over $5,000,005. On average, Capital trades about 904,160 units every 0 days since 2024. As of 11 January 2024 Capital still owns at least 4,192,216 units of Solid Biosciences Inc stock.
You can see the complete history of Capital Ra stock trades at the bottom of the page.
Over the last 7 years, insiders at Solid Biosciences Inc have traded over $9,620,465 worth of Solid Biosciences Inc stock and bought 13,973,934 units worth $97,227,521 . The most active insiders traders include Advisors Llcperceptive Life..., Capital Management, L.P.Ra ... und Rajeev M. Shah. On average, Solid Biosciences Inc executives and independent directors trade stock every 38 days with the average trade being worth of $1,822,871. The most recent stock trade was executed by Ian F Smith on 3 July 2024, trading 3,255 units of SLDB stock currently worth $24,380.
solid biosciences (solid) is a cambridge, ma based biotech company singularly focused on developing treatments and cures for duchenne muscular dystrophy (dmd). solid combines sharp commercial focus with world-class science to advance promising therapies and is positioned to catalyze therapeutic development across all aspects of the disease. condition-focused, our mandate is comprehensive; improving daily life for patients and attacking the roots of dmd.
Solid Biosciences Inc executives and other stock owners filed with the SEC include: